Survival rate of patients with systemic Lupus Erythematosus
Authors
Abstract:
Background: Due to infections, cardio-vascular involvement and renal insufficiency, patients with systemic lupus erythematosus live shorter than usual. Objective: To determine the mean survival rate of SLE patients. Patients and Methods: 62 SLE patients admitted in the hospitals of Kerman University of Medical Sciences from 1369 to 1380 were included in this study. The demographic variables, which were effective on disease survival time, evaluated. Results: Mean survival time, regardless of other descriptive variables, was 9.2±0.89 years. The cases who had skin lesions first, in comparison with those who had rheumatic signs at first, revealed lower survival rate and more morbidity. The mean survival rate of cases who received combination of corticosteroid and anti-malarial drugs, corticosteroid drugs alone, and cyclophosphamide plus anticoagulants, were 12.0, 9.5 and 8.5 years, respectively. Conclusion: The prognosis in SLE patients with early skin manifestations was poorer than those with early rheumatic presentation. Best prognosis was noted in patients who received systemic steroids in comparison to other treatment modalities.
similar resources
Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus
Background & aim: Pregnant women with systemic lupus erythematosus (SLE) are considered to be at high risk regarding fetal complications and adverse outcomes. The aim of this study was to evaluate the fetal outcomes in pregnant women with the SLE. Methods: This retrospective study was conducted on a total of 125 patients with the SLE referred to the Clinic and Department of Rheumatology of Imam...
full textNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
full textSystemic Lupus Erythematosus Patients
Previous studies demonstrated that patients with active systemic lupus erythematosus (SLE), especially those with active renal disease, had a marked reduction in T4+2H4' suppressor inducer cells in their peripheral blood. However, it was puzzling to find that active SLE patients without renal diseases often had normal percentages of T4+2H4' cells. In the present study, we attempted to determine...
full textA Case of Systemic Lupus Erythematosus
SUMMARY During the course of systemic lupus erythematosus in a 10 year-old girl, a go it er develo ped. Subc linical I ly pothyrnic.Jism was found, in addition rising titer of ant imicrosomal antibody and overt hypothyroidism after 6-week cessation of thyroxin tablet lead to the diagnosis of Hashimoto's thyroiditis. Antibodies directed to the thyroid may result in an autoimmune thyroiditis in...
full textHematologic manifestation of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. The most common hematologic finding is anemia, leukopenia, thrombocytopenia and secondary antiphospholipid syndrome with recurrent abortion and thrombosis. The autoimmune fibrosis of bone marrow is another manifestation of autoimmune disease especially SLE, that must be correctly differentiated from primary myelofibrosis.
full textMy Resources
Journal title
volume 6 issue 4
pages 17- 23
publication date 2003-07-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023